View Item 

Show simple item record

Use of allogeneic apheresis stem cell products as an interlaboratory proficiency challenge
dc.contributor.authorCooling, Laura
dc.contributor.authorRoxbury, Kelly
dc.contributor.authorHoffmann, Sandra
dc.contributor.authorDeBusscher, Joan
dc.contributor.authorKota, Usha
dc.contributor.authorGoldstein, Steven
dc.contributor.authorDavenport, Robertson
dc.date.accessioned2017-06-16T20:07:25Z
dc.date.available2018-08-07T15:51:22Zen
dc.date.issued2017-06
dc.identifier.citationCooling, Laura; Roxbury, Kelly; Hoffmann, Sandra; DeBusscher, Joan; Kota, Usha; Goldstein, Steven; Davenport, Robertson (2017). "Use of allogeneic apheresis stem cell products as an interlaboratory proficiency challenge." Transfusion 57(6): 1543-1554.
dc.identifier.issn0041-1132
dc.identifier.issn1537-2995
dc.identifier.urihttps://hdl.handle.net/2027.42/137204
dc.publisherWiley Periodicals, Inc.
dc.publisherAABB Press
dc.titleUse of allogeneic apheresis stem cell products as an interlaboratory proficiency challenge
dc.typeArticleen_US
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelOncology and Hematology
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/137204/1/trf14107.pdf
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/137204/2/trf14107_am.pdf
dc.identifier.doi10.1111/trf.14107
dc.identifier.sourceTransfusion
dc.identifier.citedreferenceVan den Bossche J, Devreese K, Malfait R, et al. Reference intervals for a complete blood count determined on different automated hematology analysers: AbxPentra 120 Retic, Coulter Gen‐S, Sysmex SE 9500, Abbot Cell Dyn 4000 and Bayer Advia 120. Clin Chem Lab Med 2002; 40: 69 ‐ 73.
dc.identifier.citedreferenceKim SY, Kim JE, Kim HK, et al. Accuracy of platelet counting by automated hematologic analyzers in acute leukemia and disseminated intravascular coagulation. Am J Clin Pathol 2010; 134: 634 ‐ 47.
dc.identifier.citedreferenceBland JM, Altman DG. Applying the right statistics: analyses of measurement studies. Ultrasound Obstet Gynecol 2003; 22: 85 ‐ 93.
dc.identifier.citedreferenceBisset LR, Lung TL, Kaelin M, et al. Reference values for peripheral blood lymphocyte phenotypes applicable to the healthy adult population in Switzerland. Eur J Haematol 2004; 203 ‐ 12.
dc.identifier.citedreferenceBarrett AJ, Ringdén O, Zhang MJ, et al. Effect of nucleated marrow cell dose on relapse and survival in identical twin bone marrow transplants for leukemia. Blood 2000; 95: 3323 ‐ 7.
dc.identifier.citedreferenceMorariu‐Zamfir R, Rocha V, Devergie A, et al. Influence of CD34(+) marrow cell dose on outcome of HLA‐identical sibling allogeneic bone marrow transplants in patients with chronic myeloid leukaemia. Bone Marrow Transplant 2001; 27: 575 ‐ 80.
dc.identifier.citedreferenceCohen YC, Scaradavou A, Stevens CE, et al. Factors affecting mortality following myeloablative cord blood transplantation in adults: a pooled analysis of three international registries. Bone Marrow Transplant 2011; 46: 70 ‐ 6.
dc.identifier.citedreferenceGambell P, Herbert K, Dickinson M, et al. Peripheral blood CD34+ cell enumeration as a predictor of apheresis yield: an analysis of more than 1,000 collections. Biol Blood Marrow Transplant 2012; 18: 763 ‐ 72.
dc.identifier.citedreferenceMeintker L, Ringwald J, Rauh M, et al. Comparison of automated differential blood cell counts from Abbot Sapphire, Siemens Advia 120, Beckman Coulter DxH 800, and Sysmex XE‐2100 in normal and pathologic samples. Am J Clin Pathol 2013; 139: 641 ‐ 50.
dc.identifier.citedreferenceChang A, Ma DD. The influence of flow cytometric gating strategy on the standardization of CD34+ cell quantitation: an Australian multicenter study. Australian BMT Scientists Study Group. J Hematother 1996; 5: 605 ‐ 16.
dc.identifier.citedreferencePreti RA, Chan WS, Kurtzberg J, et al. Multi‐site evaluation of the BD stem cell enumeration kit for CD34+ cell enumeration on the BD FACSCanto II and BD FACSCalibur flow cytometers. Cytotherapy 2014; 16: 1558 ‐ 74.
dc.identifier.citedreferenceGajkowska A, Oldak T, Jastrzewska M, et al. Flow cytometric enumeration of CD34+ hematopoietic stem and progenitor cells in leukapheresis product and bone marrow for clinical transplantation: a comparison of three methods. Folia Histochem Cytobiol 2006; 44: 53 ‐ 60.
dc.identifier.citedreferenceSerke S, Huhn D. Circulating CD34‐expressing cells: German proficiency testing survey. J Hematother 1998; 7: 37 ‐ 43.
dc.identifier.citedreferenceDe la Salle BJ, McTaggart PN, Briggs C, et al. The accuracy of platelet counting in thrombocytopenic blood samples distributed by the UK National External Quality Assessment Scheme for General Hematology. Am J Clin Pathol 2012; 137: 65 ‐ 74.
dc.identifier.citedreferencePatterson J, Moore CH, Palser E, et al. Detecting primitive hematopoietic stem cells in total nucleated and mononuclear cell fractions from umbilical cord blood segments and units. J Transl Med 2015; 13: 94.
dc.identifier.citedreferencevan Haute I, Lootens N, De Smet S, et al. Viable CD34+ stem cell content of a cord blood graft: which measurement performed before transplantation is most representative? Transfusion 2004; 44: 547 ‐ 54.
dc.identifier.citedreferenceLonza [Internet]. Homepage [cited 2016 Oct 1]. Available from: www.Lonza.com.
dc.identifier.citedreferenceEinwallner E, Subasic A, Strasser A, et al. Lysis matters: red cell lysis with FACS Lyse affects the flow cytometric enumeration of circulating leukemic blasts. J Immunol Methods 2013; 390: 127 ‐ 32.
dc.identifier.citedreferenceJoshi A, Mcvicker W, Segalla R, et al. Determining the stability of complete blood count parameters in stored blood samples using the Sysmex XE‐5000 automated haematology analyser. Int J Lab Hematol 2015; 37: 705 ‐ 14.
dc.identifier.citedreferenceAsman M, Sachdeva N, Davila L, et al. Influence of 4‐ and 6‐color flow cytometers and acquisition/analysis softwares on the determination of lymphocyte subsets in HIV infection. Cytometry B Clin Cytom 2007; 72: 380 ‐ 6.
dc.identifier.citedreferenceGutensohn K, Jessen M, Ketels A, et al. Flow cytometric analyses of CD34+ cells with inclusion of internal positive controls. Transfusion 2012; 52: 284 ‐ 90.
dc.identifier.citedreferenceStandards for cell therapy product services. 3rd ed. Bethesda (MD): AABB Press; 2008.
dc.identifier.citedreferenceFACT‐JACIE international standards for hematopoietic cellular therapy product collection, processing and administration. 6th ed. Omaha (NE): Foundation for the Accreditation of Cellular Therapy; 2015.
dc.identifier.citedreferenceCollege of American Pathologists. SCP‐A stem cell processing participant summary. Chicago (IL): College of American Pathologists; 2012.
dc.identifier.citedreferenceCollege of American Pathologists. SCP‐B stem cell processing participant summary. Chicago (IL): College of American Pathologists; 2012.
dc.identifier.citedreferenceCollege of American Pathologists. SCP‐A stem cell processing participant summary. Chicago (IL): College of American Pathologists; 2013.
dc.identifier.citedreferenceCollege of American Pathologists. SCP‐B stem cell processing participant summary. Chicago (IL): College of American Pathologists; 2013.
dc.identifier.citedreferenceCollege of American Pathologists. SCP‐A stem cell processing participant summary. Chicago (IL): College of American Pathologists; 2014.
dc.identifier.citedreferenceCollege of American Pathologists. SCP‐B stem cell processing participant summary. Chicago (IL): College of American Pathologists; 2014.
dc.identifier.citedreferenceCollege of American Pathologists. SCP‐A stem cell processing participant summary. Chicago (IL): College of American Pathologists; 2015.
dc.identifier.citedreferenceCollege of American Pathologists. SCP‐B stem cell processing participant summary. Chicago (IL): College of American Pathologists; 2015.
dc.identifier.citedreferenceBellisimo DB; American College of Medical Genetics. Practice guidelines and proficiency testing for molecular assays. Transfusion 2007; 47 ( 1 Suppl ): 79S ‐ 84S.
dc.identifier.citedreferenceBarnett D, Granger V, Storie I, et al. Quality assessment of CD34+ stem cell enumeration: experience of the United Kingdom National External Quality Assessment Scheme (UK NEQAS) using a unique stable whole blood preparation. Br J Haematol 1998; 102: 553 ‐ 65.
dc.identifier.citedreferenceBarnett D, Granger V, Kraan J, et al. Reduction of intra‐ and inter‐laboratory variation in CD34+ stem cell enumeration using stable test material, standard protocols and targeted training. DK34 Task Force of the European Working Group of Clinical Cell Analysis (EWGCCA). Br J Haematol 2000; 108: 784 ‐ 92.
dc.identifier.citedreferenceLevering WH, Preijers FW, van Wieringen WN, et al. Flow cytometric CD34+ stem cell enumeration: lessons from nine years’ external quality assessment with the Benelux countries. Cytometry B Clin Cytom 2007; 72: 178 ‐ 88.
dc.identifier.citedreferenceLysak D, Kalina T, Martinek J, et al. Interlaboratory variability of CD34+ stem cell enumeration. A pilot study to national external quality assessment within the Czech Republic. Int J Lab Hematol 2010; 32: e229 ‐ 36.
dc.identifier.citedreferenceLópez MC, Lawrence DA. Proficiency testing experience for viable CD34+ stem cell analysis. Transfusion 2008; 48: 1115 ‐ 21.
dc.identifier.citedreferenceWhitby A, Whitby L, Fletcher M, et al. ISHAGE protocol: are we doing it correctly? Cytometry B Clin Cytom 2012; 82: 9 ‐ 17.
dc.identifier.citedreferenceBrecher ME, Sims L, Schmitz J, et al. North American multicenter study on flow cytometric enumeration of CD34+ hematopoietic stem cells. J Hematother 1996; 5: 227 ‐ 36.
dc.identifier.citedreferenceSutherland DR, Anderson L, Keeney M, et al. The ISHAGE guidelines for CD34+ cell determination by flow cytometry. J Hematother 1996; 5: 213 ‐ 26.
dc.identifier.citedreferenceGratama JW, Kraan J, Levering W, et al. Analysis of variation in results of CD34+ hematopoietic progenitor cell enumeration in a multicenter study. Cytometry 1997; 30: 109 ‐ 17.
dc.identifier.citedreferenceHo HT, Lin CC, Lin J. Variation of CD34+ cell enumeration of cord blood with additional CD14 gating by flow cytometry. Lab Med 2003; 34: 481 ‐ 5.
dc.identifier.citedreferenceWeaver CH, Hazelton B, Birch R, et al. An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy. Blood 1995; 86: 3961 ‐ 9.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
trf14107.pdf
Size:
509.5KB
Format:
PDF
View/Open
Name:
trf14107_am.pdf
Size:
1.250MB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.